Canara HSBC Life IPO Analyzed
Canara HSBC Life Insurance is planning to sell shares to the public for the first time. They want to raise money – specifically, ₹2,517.5 crore – through this sale. This means investors can buy shares in the company, and it’s happening on Friday, October 10, 2025.
Key Points
- Company raising ₹2,517.5 crore through IPO launch.
- Shares for sale: 237.5 million equity shares.
- Investors can bid from October 10th – October 14th, 2025.
- Allotment expected on October 15th, 2025, shares on October 16th, 2025.
- Price range: ₹100 to ₹106 per share, lot size: 140 shares.
- Shares will debut on NSE and BSE tentatively on October 17th, 2025.
The sale involves Canara Bank and HSBC Insurance (Asia-Pacific) Holdings, who currently own the company. Punjab National Bank is also selling shares. Investors can choose to buy shares from them.
The company is splitting the sale into different categories for investors. They’ve set aside 50% of the shares for “Qualified Institutional Buyers” (those with a lot of money), 15% for “Non-Institutional Investors,” and 35% for regular retail investors – people like you and me.
Experts are giving opinions on the IPO. SBI Securities believes Canara HSBC Life Insurance is doing well because of its strong connections with banks and how it sells its products. They predict that insurance sales will grow quickly, which could help the company grow too.
Kunvarji Wealth Solutions recommends buying the shares for the long term, because of the company’s famous parent companies, good finances, and high accuracy in paying out claims. The company also sells its products through many different channels.
The sale will last for three days: October 10th, 11th, and 14th, 2025. If you win the chance to buy shares, they’ll give them to you on October 15th, 2025, and you’ll actually start trading them on the stock market on October 17th, 2025.
The price range for the shares is between ₹100 and ₹106. To buy even one lot, you need to invest at least ₹14,840. Kfin Technologies is in charge of managing the sale process.
Investing in IPOs carries risk, and decisions should be based on thorough research.
